Entero Healthcare Solutions Ltd
Wed 30/04/2025,15:59:47 | NSE : ENTERO
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1360.00
Previous Close
₹ 1344.40
Volume
75569
Mkt Cap ( Rs. Cr)
₹5717.26
High
₹ 1384.40
Low
₹ 1300.00
52 Week High
₹ 1584.25
52 Week Low
₹ 991.10
Book Value Per Share
₹ 386.91
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Entero Healthcare Solutions Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Entero Healthcare So - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Entero Healthcare So has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Entero Healthcare So - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Entero Healthcare So - Update-Acquisition/Scheme/Sale/Disposal-XBRL
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Entero Healthcare So - Acquisition
-
Entero Healthcare So - Trading Window
-
Entero Healthcare So - Trading Window-XBRL
-
Entero Healthcare So - Sale or disposal-XBRL
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Change in Management
-
Entero Healthcare So - Change in Management
-
Entero Healthcare So - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Held On March 21, 2025
-
Entero Healthcare So - Outcome of Board Meeting
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Entero Healthcare So - Press Release
-
Entero Healthcare So - Press Release
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Entero Healthcare So - General Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Entero Healthcare So - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Intimation Of Cancellation Of Analyst/ Institutional Investor Meeting Scheduled On February 21, 2025
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Copy of Newspaper Publication
-
Entero Healthcare So - Investor Presentation
-
Entero Healthcare So - Statement Of Deviation For The Quarter Ended December 31, 2024
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Entero Healthcare So - Statement of deviation(s) or variation(s) under Reg. 32
-
Entero Healthcare So - Monitoring Agency Report
-
Entero Healthcare So - Integrated Filing (Financial)
-
Entero Healthcare So - Integrated Filing- Financial
-
Entero Healthcare So - Outcome of Board Meeting
-
Entero Healthcare So - Financial Result Updates
-
Entero Healthcare So Q3 net profit zooms 1034.74% at Rs 10.78 cr
-
Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Held On February 12, 2025
-
Entero Healthcare So - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2024
-
Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates
-
Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Entero Healthcare So - Board Meeting Intimation
-
Entero Healthcare So - Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Fin
Key fundamentals
Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | |
---|---|---|---|---|---|
Assets | 1626.414 | 675.232 | 581.205 | 486.4381 | |
Liabilities | 1626.414 | 675.232 | 581.205 | 486.4381 | |
Equity | 43.494 | 4.112 | 3.85 | 0.1002 | |
Gross Profit | -34.494 | -43.916 | -53.716 | -36.9478 | |
Net Profit | 38.44 | -12.455 | -40.847 | -18.1512 | |
Cash From Operating Activities | -75.65 | -56.909 | -44.698 | -68.1958 | |
NPM(%) | 12.08 | -7 | -29.75 | -18.17 | |
Revenue | 318.161 | 177.69 | 137.286 | 99.8955 | |
Expenses | 352.655 | 221.606 | 191.002 | 136.8433 | |
ROE(%) | 2.28 | -0.74 | -2.42 | -1.07 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 825.75 | -1.80 | 11.65 | 751.30 | 1321.50 | 1.39 |
Lotus Eye Hospital and Institute Ltd | 81.22 | -0.17 | 338.42 | 2737.62 | 14.01 | 0.62 |
Vaishali Pharma Ltd | 13.47 | -1.82 | 449.00 | 1411.08 | 2.76 | 0.00 |
Astec Lifesciences Ltd | 685.90 | -1.03 | 0.00 | 2581.34 | -687.11 | 0.00 |
Company Info
Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.
Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.
Read More
Parent Organisation
Entero Healthcare Solutions Ltd.
Founded
10/01/2018
Managing Director
Mr.Prabhat Agrawal
NSE Symbol
ENTEROEQ
FAQ
The current price of Entero Healthcare Solutions Ltd is ₹ 1314.50.
The 52-week high for Entero Healthcare Solutions Ltd is ₹ 1384.40 and the 52-week low is ₹ 1300.00.
The market capitalization of Entero Healthcare Solutions Ltd is currently ₹ 5717.26. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Entero Healthcare Solutions Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Entero Healthcare Solutions Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Entero Healthcare Solutions Ltd shares.
The CEO of Entero Healthcare Solutions Ltd is Mr.Prabhat Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.